Immuneering saw some selling pressure today and moved down -3.11%
The company isn't at an immediate support or resistance level that might be predictive. Immuneering hasn't shown a lot of strength recently, shareholders don't seem that energized about the asset's future prospects. IMRX might find some support at the 5.66 level, buyers might push the price back up from here. But it's not very clear what will happen.